首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Mycobacterium tuberculosis Region of Difference (RD) 2 Antigen Rv1985c and RD11 Antigen Rv3425 Have the Promising Potential To Distinguish Patients with Active Tuberculosis from M. bovis BCG-Vaccinated Individuals
【2h】

Mycobacterium tuberculosis Region of Difference (RD) 2 Antigen Rv1985c and RD11 Antigen Rv3425 Have the Promising Potential To Distinguish Patients with Active Tuberculosis from M. bovis BCG-Vaccinated Individuals

机译:结核分枝杆菌差异区(RD)2抗原Rv1985c和RD11抗原Rv3425具有将牛结核分枝杆菌BCG疫苗接种个体与活动性肺结核患者区分开的潜力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Antigens encoded in the region of difference (RD) of Mycobacterium tuberculosis constitute a potential source of specific immunodiagnostic antigens for distinguishing tuberculosis (TB) infection from BCG vaccination. We evaluated the diagnostic potential of specific T-cell epitopes selected from two immunodominant antigens, Rv1985c and Rv3425, from RD2 and RD11, respectively, on the basis of epitope mapping, in TB patients and BCG-vaccinated healthy individuals. Using a whole-blood gamma interferon release assay, a wide array of epitopes was recognized on both Rv1985c and Rv3425 in TB patients. Those epitopes that could specifically discriminate TB infection from BCG vaccination were carefully selected, and the most promising peptide pools from Rv1985c showed a sensitivity of 53.9% and a specificity of 95.5%. When the novel specific peptides from Rv1985c joined the diagnostic antigens in the QuantiFERON-TB Gold In-Tube (QFT-IT) assay, the sensitivity was increased from 86.4% to 96.2%, with no drop in specificity. These results indicate that the peptide pools selected from Rv1985c and Rv3425 have the potential to diagnose TB infection by a method that may be routinely used in clinical laboratories.
机译:结核分枝杆菌差异区(RD)中编码的抗原构成了特异性免疫诊断抗原的潜在来源,可用于将结核病(TB)感染与卡介苗接种区别开来。我们基于表位作图,评估了分别选自RD2和RD11的两种免疫显性抗原Rv1985c和Rv3425的特定T细胞表位在TB患者和接种BCG的健康个体中的诊断潜力。使用全血γ干扰素释放测定法,在结核病患者的Rv1985c和Rv3425上都可以识别多种表位。精心选择了那些可以从BCG疫苗中特异性区分TB感染的表位,Rv1985c最有希望的肽库显示出53.9%的灵敏度和95.5%的特异性。当来自Rv1985c的新型特异性肽在QuantiFERON-TB金管中(QFT-IT)分析中加入诊断抗原时,灵敏度从86.4%增加到96.2%,特异性没有下降。这些结果表明,选自Rv1985c和Rv3425的肽库具有通过临床实验室常规使用的方法诊断结核感染的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号